Skip to main content

Table 15 Long-term stability results of amivantamab—Day 21

From: Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS

Replicate no

HQC (75.0 ng/ml)

LQC (25.0 ng/ml)

MQC (50.0 ng/ml)

Concentration (ng/ml)

1

73.6

21.9

46.8

2

73.6

21.9

47.5

3

73.6

22.6

47.5

4

74.2

22.6

47.5

5

72.9

22.6

48.1

6

73.6

21.9

46.8

Mean

73.6

22.3

47.4

SD

0.4

0.3

0.5

% CV

0.5

1.5

0.9

% Mean accuracy

97.6%

89.2%

94.7%